Browsing by Author "Duzenli, Tolga"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Helicobacter pylori treatment in Turkey: Current status and rational treatment options(KARE PUBL, 2020-01-01) Kaplan, Mustafa; Tanoglu, Alpaslan; Duzenli, Tolga; Tozun, Ayse NurdanAccording to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5\%. After FDA approval in 1995, many countries have used standard triple therapy (proton pump inhibitor 40 mg b.i.d clarithromycin 500 mg b.i.d and amoxicillin 1 gr b.i.d) for Helicobacter pylori treatment. In the beginning, eradication rates were above 90\% in many countries